Matricellular proteins as possible biomarkers for early brain injury after aneurysmal subarachnoid hemorrhage
Aneurysmal subarachnoid hemorrhage remains devastating, and the most important determinant of poor outcome is early brain injury (EBI). In clinical settings, as a surrogate marker of EBI, loss of consciousness at ictus, poor initial clinical grades, and some radiographic findings are used, but these...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
| Series: | Neural Regeneration Research |
| Subjects: | |
| Online Access: | http://www.nrronline.org/article.asp?issn=1673-5374;year=2018;volume=13;issue=7;spage=1175;epage=1178;aulast=Suzuki |
| _version_ | 1818411979828625408 |
|---|---|
| author | Hidenori Suzuki Hirofumi Nishikawa Fumihiro Kawakita |
| author_facet | Hidenori Suzuki Hirofumi Nishikawa Fumihiro Kawakita |
| author_sort | Hidenori Suzuki |
| collection | DOAJ |
| description | Aneurysmal subarachnoid hemorrhage remains devastating, and the most important determinant of poor outcome is early brain injury (EBI). In clinical settings, as a surrogate marker of EBI, loss of consciousness at ictus, poor initial clinical grades, and some radiographic findings are used, but these markers are somewhat subjective. Thus, it is imperative to find biomarkers of EBI that have beneficial prognostic and therapeutic implications. In our opinion, an ideal biomarker is a molecule that is implicated in the pathogenesis of both EBI and subsequently developing delayed cerebral ischemia (DCI), being a therapeutic target, and can be measured easily in the peripheral blood in an acute stage. A good candidate of such a biomarker is a matricellular protein, which is a secreted, inducible and multifunctional extracellular matrix protein. There are many kinds of matricellular proteins reported, but only tenascin-C, osteopontin, galectin-3 and periostin are reported relevant to EBI and DCI. Reliable biomarkers of EBI may stratify aneurysmal subarachnoid hemorrhage patients into categories of risk to develop DCI, and allow objective monitoring of the response to treatment for EBI and earlier diagnosis of DCI. This review emphasizes that further investigation of matricellular proteins as an avenue for biomarker discovery is warranted. |
| first_indexed | 2024-12-14T10:40:01Z |
| format | Article |
| id | doaj.art-3c4abb30a68b4eba9f54bdb6b0c891aa |
| institution | Directory Open Access Journal |
| issn | 1673-5374 |
| language | English |
| last_indexed | 2024-12-14T10:40:01Z |
| publishDate | 2018-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Neural Regeneration Research |
| spelling | doaj.art-3c4abb30a68b4eba9f54bdb6b0c891aa2022-12-21T23:05:44ZengWolters Kluwer Medknow PublicationsNeural Regeneration Research1673-53742018-01-011371175117810.4103/1673-5374.235022Matricellular proteins as possible biomarkers for early brain injury after aneurysmal subarachnoid hemorrhageHidenori SuzukiHirofumi NishikawaFumihiro KawakitaAneurysmal subarachnoid hemorrhage remains devastating, and the most important determinant of poor outcome is early brain injury (EBI). In clinical settings, as a surrogate marker of EBI, loss of consciousness at ictus, poor initial clinical grades, and some radiographic findings are used, but these markers are somewhat subjective. Thus, it is imperative to find biomarkers of EBI that have beneficial prognostic and therapeutic implications. In our opinion, an ideal biomarker is a molecule that is implicated in the pathogenesis of both EBI and subsequently developing delayed cerebral ischemia (DCI), being a therapeutic target, and can be measured easily in the peripheral blood in an acute stage. A good candidate of such a biomarker is a matricellular protein, which is a secreted, inducible and multifunctional extracellular matrix protein. There are many kinds of matricellular proteins reported, but only tenascin-C, osteopontin, galectin-3 and periostin are reported relevant to EBI and DCI. Reliable biomarkers of EBI may stratify aneurysmal subarachnoid hemorrhage patients into categories of risk to develop DCI, and allow objective monitoring of the response to treatment for EBI and earlier diagnosis of DCI. This review emphasizes that further investigation of matricellular proteins as an avenue for biomarker discovery is warranted.http://www.nrronline.org/article.asp?issn=1673-5374;year=2018;volume=13;issue=7;spage=1175;epage=1178;aulast=Suzukibiomarker; early brain injury; galectin-3; matricellular protein; osteopontin; periostin; subarachnoid hemorrhage; tenascin-C |
| spellingShingle | Hidenori Suzuki Hirofumi Nishikawa Fumihiro Kawakita Matricellular proteins as possible biomarkers for early brain injury after aneurysmal subarachnoid hemorrhage Neural Regeneration Research biomarker; early brain injury; galectin-3; matricellular protein; osteopontin; periostin; subarachnoid hemorrhage; tenascin-C |
| title | Matricellular proteins as possible biomarkers for early brain injury after aneurysmal subarachnoid hemorrhage |
| title_full | Matricellular proteins as possible biomarkers for early brain injury after aneurysmal subarachnoid hemorrhage |
| title_fullStr | Matricellular proteins as possible biomarkers for early brain injury after aneurysmal subarachnoid hemorrhage |
| title_full_unstemmed | Matricellular proteins as possible biomarkers for early brain injury after aneurysmal subarachnoid hemorrhage |
| title_short | Matricellular proteins as possible biomarkers for early brain injury after aneurysmal subarachnoid hemorrhage |
| title_sort | matricellular proteins as possible biomarkers for early brain injury after aneurysmal subarachnoid hemorrhage |
| topic | biomarker; early brain injury; galectin-3; matricellular protein; osteopontin; periostin; subarachnoid hemorrhage; tenascin-C |
| url | http://www.nrronline.org/article.asp?issn=1673-5374;year=2018;volume=13;issue=7;spage=1175;epage=1178;aulast=Suzuki |
| work_keys_str_mv | AT hidenorisuzuki matricellularproteinsaspossiblebiomarkersforearlybraininjuryafteraneurysmalsubarachnoidhemorrhage AT hirofuminishikawa matricellularproteinsaspossiblebiomarkersforearlybraininjuryafteraneurysmalsubarachnoidhemorrhage AT fumihirokawakita matricellularproteinsaspossiblebiomarkersforearlybraininjuryafteraneurysmalsubarachnoidhemorrhage |